Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “inhibitors”

2,466 pharma patents match "inhibitors" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,466
Index total 30,257
Page 3 / 103

Quick answer

This filtered view shows 2,466 pharmaceutical patents matching "inhibitors" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,466 results for “inhibitors” · 30,257 patents in full index Clear search

  1. US 12343380

    Expansion of TILs utilizing AKT pathways inhibitors

    Iovance Biotherapeutics, Inc. · Granted Jul 1, 2025 · Expires Jun 26, 2045

    granted
  2. US 12338242

    TYK2 inhibitors and uses thereof

    Takeda Pharmaceutical Company Limited · Granted Jun 24, 2025 · Expires Jun 19, 2045

    granted
  3. US 12331026

    Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors

    NIKANG THERAPEUTICS, INC. · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  4. US 12331056

    SHP2 phosphatase inhibitors and methods of use thereof

    Relay Therapeutics, Inc. · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  5. US 12331036

    Heterocyclic RIP1 kinase inhibitors

    Rigel Pharmaceuticals, Inc. · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  6. US 12329748

    Anhydrous compositions of mTOR inhibitors and methods of use

    PALVELLA THERAPEUTICS, INC. · Granted Jun 17, 2025 · Expires Jun 12, 2045

    granted
  7. US 12318386

    Combination of XPO1 inhibitors and second agents for the treatment of prostate cancer

    Karyopharm Therapeutics Inc. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  8. US 12319703

    Macrocyclic fused pyrazoles as Mcl-1 inhibitors

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  9. US 12312339

    Polo like kinase 4 inhibitors

    ORIC PHARMACEUTICALS, INC. · Granted May 27, 2025 · Expires May 22, 2045

    granted
  10. US 12312348

    RET inhibitors, pharmaceutical compositions and uses thereof

    SUNSHINE LAKE PHARMA CO., LTD. · Granted May 27, 2025 · Expires May 22, 2045

    granted
  11. US 12304912

    Fused bicyclic RAF inhibitors and methods for use thereof

    Jazz Pharmaceuticals Ireland Limited · Granted May 20, 2025 · Expires May 15, 2045

    granted
  12. US 12297186

    Benzylamide derivatives as inhibitors of transforming growth factor-beta receptor I/ALK5

    AGOMAB SPAIN, S.L.U. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  13. US 12295941

    Viral inhibitors, the synthesis thereof, and intermediates thereto

    Takeda Pharmaceutical Company Limited · Granted May 13, 2025 · Expires May 8, 2045

    granted
  14. US 12295940

    Viral inhibitors, the synthesis thereof, and intermediates thereto

    Takeda Pharmaceutical Company Limited · Granted May 13, 2025 · Expires May 8, 2045

    granted
  15. US 12297203

    Pyrrolopyrimidine ITK inhibitors

    Aclaris Therapeutics, Inc. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  16. US 12297202

    RIP1K inhibitors

    Rigel Pharmaceuticals, Inc. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  17. US 12297209

    Benzodiazepine derivatives as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted May 13, 2025 · Expires May 8, 2045

    granted
  18. US 12291502

    Topoisomerase II-alpha inhibitors and methods of treating cancer using the same

    The Regents of the University of Colorado, a Body Corporate · Granted May 6, 2025 · Expires May 1, 2045

    granted
  19. US 12286406

    Inhibitors of receptor interacting protein kinase I for the treatment of disease

    The Board of Regents of the University of Texas System · Granted Apr 29, 2025 · Expires Apr 24, 2045

    granted
  20. US 12280113

    Ras inhibitors

    Revolution Medicines, Inc. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  21. US 12280063

    Anti-retroviral therapies and reverse transcriptase inhibitors for treatment of Alzheimer's disease

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  22. US 12281122

    PI3K inhibitors

    Cogent Biosciences, Inc. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  23. US 12281111

    Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same

    Aclaris Therapeutics, Inc. · Granted Apr 22, 2025 · Expires Apr 17, 2045

    granted
  24. US 12268694

    Combination pharmaceutical agents as RSV inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Apr 8, 2025 · Expires Apr 3, 2045

    granted